Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model
Conferences
Anderson, BR; Davis, EE; Telen, MJ; Ashley-Koch, AE
Published in: BLOOD
December 6, 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 6, 2014
Volume
124
Issue
21
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Anderson, B. R., Davis, E. E., Telen, M. J., & Ashley-Koch, A. E. (2014). Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model. In BLOOD (Vol. 124). AMER SOC HEMATOLOGY.
Anderson, Blair R., Erica E. Davis, Marilyn J. Telen, and Allison E. Ashley-Koch. “Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model.” In BLOOD, Vol. 124. AMER SOC HEMATOLOGY, 2014.
Anderson BR, Davis EE, Telen MJ, Ashley-Koch AE. Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model. In: BLOOD. AMER SOC HEMATOLOGY; 2014.
Anderson, Blair R., et al. “Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model.” BLOOD, vol. 124, no. 21, AMER SOC HEMATOLOGY, 2014.
Anderson BR, Davis EE, Telen MJ, Ashley-Koch AE. Evidence for a Dominant Negative Effect Conferred By the APOL1 G2 Sickle Cell Nephropathy Risk Allele in an in Vivo Model. BLOOD. AMER SOC HEMATOLOGY; 2014.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 6, 2014
Volume
124
Issue
21
Publisher
AMER SOC HEMATOLOGY
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology